Wang Xin, Zeng Xuejun, Zhang Xiao, Wei Jianping, Zhang Yuxiang, Long Fangyu, Yue Tianli, Yuan Yahong
College of Food Science and Engineering, Northwest A&F University, Yangling, China.
Laboratory of Quality and Safety Risk Assessment for Agro-products (YangLing), Ministry of Agriculture, Yangling, China.
J Sci Food Agric. 2023 Mar 15;103(4):1736-1748. doi: 10.1002/jsfa.12334. Epub 2022 Dec 2.
Probiotics are regarded as a promising strategy for relieving colitis caused by dextran sulfate sodium (DSS). One of the dominant probiotic fungi in Fuzhuan brick tea is identified as Aspergillus cristatus, but whether it can effectively improve colitis remains poorly understood. Here, the improving effect of A. cristatus on colitis was investigated.
Our results showed that A. cristatus intervention prominently alleviated gut damage as evidenced by the inhibition of shortened colon length, goblet cell depletion, and histological injury. Mechanistically, after administration with low concentrations of A. cristatus H-1 and A. cristatus S-6, the expression of interleukin-6, tumor necrosis factor-α, interleukin-1β, nitric oxide, and malondialdehyde were significantly downregulated, and the content of glutathione, catalase, interleukin-10, immunoglobulin G, claudin-1, occludin, and zonula occludens-1 were effectively upregulated. More importantly, live A. cristatus supplementation lightened DSS-induced gut barrier damage by suppressing activation of the mitogen-activated protein kinase (MAPK) signaling pathway, increasing the synthesis of short-chain fatty acids (SCFAs) and stimulating the increase in peroxisome proliferator-activated receptor γ expression.
Together, A. cristatus can attenuate DSS-induced intestinal barrier damage through reducing the oxidative stress, regulating SCFA and inhibiting MAPK signaling pathways (P38/JNK/ERK). Our findings indicate that A. cristatus replenishment has potential as a new probiotic fungi to reduce DSS-induced colitis. © 2022 Society of Chemical Industry.
益生菌被认为是缓解葡聚糖硫酸钠(DSS)所致结肠炎的一种有前景的策略。茯砖茶中占主导地位的益生菌真菌之一被鉴定为冠突曲霉,但它是否能有效改善结肠炎仍知之甚少。在此,对冠突曲霉对结肠炎的改善作用进行了研究。
我们的结果表明,冠突曲霉干预显著减轻了肠道损伤,这表现为结肠长度缩短、杯状细胞缺失和组织学损伤受到抑制。从机制上讲,在给予低浓度的冠突曲霉H-1和冠突曲霉S-6后,白细胞介素-6、肿瘤坏死因子-α、白细胞介素-1β、一氧化氮和丙二醛的表达显著下调,而谷胱甘肽、过氧化氢酶、白细胞介素-10、免疫球蛋白G、闭合蛋白-1、闭锁蛋白和紧密连接蛋白-1的含量有效上调。更重要的是,补充活的冠突曲霉通过抑制丝裂原活化蛋白激酶(MAPK)信号通路的激活、增加短链脂肪酸(SCFA)的合成以及刺激过氧化物酶体增殖物激活受体γ表达的增加,减轻了DSS诱导的肠道屏障损伤。
总之,冠突曲霉可通过降低氧化应激、调节短链脂肪酸和抑制MAPK信号通路(P38/JNK/ERK)来减轻DSS诱导的肠道屏障损伤。我们的研究结果表明,补充冠突曲霉作为一种新的益生菌真菌具有减轻DSS诱导的结肠炎的潜力。© 2022化学工业协会。